Overview Absolute Bioavailability of YH4808 With Accelerator Mass Spectrometry(AMS)-Based Microdose Study Status: Completed Trial end date: 2014-04-01 Target enrollment: Participant gender: Summary This study aims to determine the absolute bioavailability of YH4808 using simultaneous oral therapeutic- and [14C]-labeled intravenous microdoses. Phase: Early Phase 1 Details Lead Sponsor: Seoul National University Hospital